advertisement
Liu D 21
Showing records 1 to 21 | Display all abstracts from Liu D98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Fang F
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
He C
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98544 Brain Functional Network Analysis of Patients with Primary Angle-Closure Glaucoma
Liu D; Gao J
Disease markers 2022; 2022: 2731007
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Zhuang P
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Zhang G
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98544 Brain Functional Network Analysis of Patients with Primary Angle-Closure Glaucoma
You T
Disease markers 2022; 2022: 2731007
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Feng X
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Fu J; Zhang R
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu P
Molecular Therapy 2022; 30: 1421-1431
98544 Brain Functional Network Analysis of Patients with Primary Angle-Closure Glaucoma
Li S
Disease markers 2022; 2022: 2731007
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu D
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Li A
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98544 Brain Functional Network Analysis of Patients with Primary Angle-Closure Glaucoma
Cai F; Pei C
Disease markers 2022; 2022: 2731007
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Huang H
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Liu D; Li B
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98544 Brain Functional Network Analysis of Patients with Primary Angle-Closure Glaucoma
Zeng X
Disease markers 2022; 2022: 2731007
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Li L; Chen W
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Chen Y; Deng B
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu L; Sun Y; Jiang H
Molecular Therapy 2022; 30: 1421-1431
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Shuai P; Lu F
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Ye J; Hu Y
Molecular Therapy 2022; 30: 1421-1431
